Clover Corp Ltd (ASX: CLV) Share Price and News

Mr Glasson is former CEO of PGG Wrightson based in Christchurch, New Zealand. He was formerly CEO of Gold Coin Group / Zuellig Agriculture which managed a portfolio of animal feed operations and farming ventures throughout South East Asia. Prior to that he was CEO for seven years of Sucrogen (formerly the sugar business of listed entity CSR and now owned by Wilmar) which generated revenues of nearly $2 billion and had contacts across the local and international food and beverage sector and retail market. He has also had agribusiness experience with Goodman Fielder and Gresham Rabo, as well as spending the first sixteen years of his career in the oil and gas sector with Esso. He is Chair of the People & Culture Committee and member of Risk Committee.

Ms Brendish has more than 30 years' experience working in blue chip FMCG, healthcare, manufacturing, agriculture, and telecommunication companies in Asia, Australia, and New Zealand, including over 20 years in Chief Executive Officer / Managing Director roles. Toni Brendish's most recent executive role was as Chief Executive Officer of Westland Milk Products in the South Island of New Zealand. Prior to this, Toni spent 11 years working for the Danone Group as Managing Director of their Infant Formula and Dairy businesses in Australia, New Zealand, Malaysia and Indonesia. She has also worked for Kimberly-Clark and Colgate Palmolive, together with a number of other blue chip FMCG organisations. Toni was recently appointed as Chair of Fresh Produce Group (1 July 2025). Toni remains a representative director on the board of Prolife Food (NZ) Limited, a private New Zealand consumer foods business. Toni recently resigned from the board advisory committee of Aurora Dairies (31 July 2025). She is member of Risk Committee and People & Culture Committee.

Mr Harrington is an experienced company Director with over 30 years' experience as a Non-Executive Director of companies operating in manufacturing, industrial services, health and technology. He has been involved in private equity since 1987 and is considered to be one of the founders of the Australian industry. Mr Harrington was previously a Non-Executive Director of Bradken Limited, Advent Partners and others.

Mr Davey has a record of building businesses across a range of industry sectors. He has held senior management positions within a number of manufacturing and distribution companies operating in competitive and diverse markets. Mr Davey has strengths in sales and marketing, and development and implementation of strategies for growth. Mr Davey was formerly Executive Manager AgriProducts and a director of Viterra Australia Limited, responsible for the AgriProducts division that traded in agricultural inputs, fertilizer, seed and wool. In earlier roles, Mr Davey headed the Sales and Marketing divisions of FMP Products and Hi Fert Pty Ltd. During his career, Mr Davey has had a focus on marketing-based businesses operating in the Asia and Oceania regions. Other current Non-Executive Company directorships include Chairman of Melody Dairies Ltd Partnership (appointed 30 October 2018).

Dr Green has 32 years of experience in the biotechnology industry focused on the discovery, development and commercialisation of life saving medicines. He was involved in CSL's global expansion over a 17-year period and held roles as Senior Vice President, Global Plasma R&D and General Manager of CSL's manufacturing plants in Germany and Australia. Simon is currently the founder and CEO of Immunosis Pty Ltd, a start-up diagnostics Company. He is Chair of the Innovation & Development Committee and member of Risk and People & Culture Committee

Ms Pearse has commercial expertise from a Commercial, Finance and Tax career during almost two decades at ASX-listed, global companies BHP Billiton and BlueScope Steel. Fiona is the current Chair of the Board of U Ethical. She is also a Non-Executive Director, and Chair of the Risk and Audit Committee of Smart Parking (ASX: SPZ), and a Non-Executive Director of Monash Health.

-

-